PPARG and Hypertension: No statistically significant differences were observed in sex, hypertension, or the use of ACEi, ARB, β-blockers, CCB, statins, fibrate, metformin, sulfonylureas, DDP-4 inhibitors, PPAR-γ agonists, or insulin between the two groups.